Search Results - "Buxò, Elvira"

Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer by Jiménez-Fonseca, Paula, Carmona-Bayonas, Alberto, Sánchez Lorenzo, Maria Luisa, Plazas, Javier Gallego, Custodio, Ana, Hernández, Raquel, Garrido, Marcelo, García, Teresa, Echavarría, Isabel, Cano, Juana María, Rodríguez Palomo, Alberto, Mangas, Monserrat, Macías Declara, Ismael, Ramchandani, Avinash, Visa, Laura, Viudez, Antonio, Buxó, Elvira, Díaz-Serrano, Asunción, López, Carlos, Azkarate, Aitor, Longo, Federico, Castañón, Eduardo, Sánchez Bayona, Rodrigo, Pimentel, Paola, Limón, Maria Luisa, Cerdá, Paula, Álvarez Llosa, Renata, Serrano, Raquel, Lobera, Maria Pilar Felices, Alsina, María, Hurtado Nuño, Alicia, Gómez-Martin, Carlos

“…Background Trastuzumab significantly improves overall survival (OS) when added to cisplatin and fluoropyrimidine as a treatment for HER2-positive advanced…”
Get full text

Identification of docetaxel resistance genes in castration-resistant prostate cancer by Marín-Aguilera, Mercedes, Codony-Servat, Jordi, Kalko, Susana G, Fernández, Pedro L, Bermudo, Raquel, Buxo, Elvira, Ribal, María José, Gascón, Pedro, Mellado, Begoña

“…Docetaxel-based chemotherapy is the standard first-line therapy in metastatic castration-resistant prostate cancer (CRPC). However, most patients eventually…”
Get full text

Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study by Fernández, Ana, Salgado, Mercedes, García, Adelaida, Buxò, Elvira, Vera, Ruth, Adeva, Jorge, Jiménez-Fonseca, Paula, Quintero, Guillermo, Llorca, Cristina, Cañabate, Mamen, López, Luis Jesús, Muñoz, Andrés, Ramírez, Patricia, González, Paula, López, Carlos, Reboredo, Margarita, Gallardo, Elena, Sanchez-Cánovas, Manuel, Gallego, Javier, Guillén, Carmen, Ruiz-Miravet, Nuria, Navarro-Pérez, Víctor, De la Cámara, Juan, Alés-Díaz, Inmaculada, Pazo-Cid, Roberto Antonio, Carmona-Bayonas, Alberto

“…Treatment with nab-paclitaxel plus gemcitabine increases survival in patients with metastatic pancreatic cancer. However, the assessment of treatment efficacy…”
Get full text

Intravenous 5-Fluorouracil in Patients With Advanced Squamous Cell Carcinoma: A Retrospective Study by Buxó, Elvira, Sosa, Aaron, Reig, Oscar, Victoria, Ivan, Caballero, Miguel, Grau, Juan José, Garcia-Morillo, Marcial

“…Objectives: In the EXTREME trial, a combination of cisplatin or carboplatin plus 5-fluorouracil (5-FU) and cetuximab was superior to cisplatin/carboplatin plus…”
Get full text

Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma? by Perlaza, Pilar, Ortín, Jaime, Pagès, Mario, Buxó, Elvira, Fernández-Esparrach, Gloria, Colletti, Patrick M, Rubello, Domenico, Mayoral, Maria, Sánchez, Nuria, Ruiz, Cristina, Ginés, Angels, Fuster, David

“…PURPOSEThe aim of this study was to evaluate F-FDG PET/CT compared with conventional imaging techniques in the clinical management of patients with locally…”
Get full text

Real-life use of ramucirumab in gastric cancer in Spain: the RAMIS study by Longo, Federico, Jorge, Mónica, Yaya, Ricardo, Montes, Ana Fernández, Lago, Nieves Martínez, Brozos, Elena, Aparicio, Jorge, Quintero, Guillermo, Ceballos, Eduardo, Buxó, Elvira, Lopez, Ana Maria, Pellón, Maria Luz, Molina, Raquel, Diaz-Paniagua, Laura, Cerdà, Paula, Leiva, Pedro Lopez, Carnicero, Alfonso Martín, Cousillas, Antía, Paris, Lorena, García-Paredes, Beatriz, Romero, Carlos, Ortega, María, Molero, Alberto, la Torre, Sergio de, Jen, Min-Hua, Díaz-Cerezo, Silvia

“…To obtain real-world data on ramucirumab use and effectiveness for the treatment of advanced gastric cancer (AGC) or gastroesophageal junction adenocarcinoma…”
Get full text

On the Effect of Triplet or Doublet Chemotherapy in Advanced Gastric Cancer: Results From a National Cancer Registry by Carmona-Bayonas, Alberto, Jiménez-Fonseca, Paula, Lorenzo, Maria Luisa Sánchez, Ramchandani, Avinash, Martínez, Elena Asensio, Custodio, Ana, Garrido, Marcelo, Echavarría, Isabel, Cano, Juana María, Barreto, Jose Enrique Lorenzo, García, Teresa García, Manceñido, Felipe Álvarez, Lacalle, Alejandra, Cardona, Marta Ferrer, Mangas, Monserrat, Visa, Laura, Buxó, Elvira, Azkarate, Aitor, Díaz-Serrano, Asunción, Montes, Ana Fernández, Rivera, Fernando

“…There is currently no consensus regarding first-line chemotherapy for patients with advanced gastric cancer (AGC) who are ineligible to receive trastuzumab…”
Get more information

Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry by Jiménez Fonseca, Paula, Carmona-Bayonas, Alberto, Hernández, Raquel, Custodio, Ana, Cano, Juana Maria, Lacalle, Alejandra, Echavarria, Isabel, Macias, Ismael, Mangas, Monserrat, Visa, Laura, Buxo, Elvira, Álvarez Manceñido, Felipe, Viudez, Antonio, Pericay, Carles, Azkarate, Aitor, Ramchandani, Avinash, López, Carlos, Martinez de Castro, Eva, Fernández Montes, Ana, Longo, Federico, Sánchez Bayona, Rodrigo, Limón, Maria Luisa, Diaz-Serrano, Asun, Martin Carnicero, Alfonso, Arias, David, Cerdà, Paula, Rivera, Fernando, Vieitez, Jose Maria, Sánchez Cánovas, Manuel, Garrido, M, Gallego, J

Get full text

Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry by Jiménez Fonseca, Paula, Carmona-Bayonas, Alberto, Hernández, Raquel, Custodio, Ana, Cano, Juana Maria, Lacalle, Alejandra, Echavarria, Isabel, Macias, Ismael, Mangas, Monserrat, Visa, Laura, Buxo, Elvira, Álvarez Manceñido, Felipe, Viudez, Antonio, Pericay, Carles, Azkarate, Aitor, Ramchandani, Avinash, López, Carlos, Martinez de Castro, Eva, Fernández Montes, Ana, Longo, Federico, Sánchez Bayona, Rodrigo, Limón, Maria Luisa, Diaz-Serrano, Asun, Martin Carnicero, Alfonso, Arias, David, Cerdà, Paula, Rivera, Fernando, Vieitez, Jose Maria, Sánchez Cánovas, Manuel, Garrido, M, Gallego, J

“…Background: The choice of chemotherapy in HER2-negative gastric cancer is based on centre’s preferences and adverse effects profile. No schedule is currently…”
Get full text

Trial in progress: A phase I study of AMG 199, a half-life extended bispecific T-cell engager (HLE BiTE) immune therapy, targeting MUC17 in patients with gastric and gastroesophageal junction (G/GEJ) cancer by Chao, Joseph, Buxó, Elvira, Cervantes, Andrés, Dayyani, Farshid, Rocha Lima, Caio Max Sao Pedro, Greil, Richard, Van Laarhoven, Hanneke W.M., Lorenzen, Sylvie, Heinemann, Volker, Kischel, Roman, Shitara, Kohei, Lordick, Florian

“…Abstract only TPS4649 Background: Prognosis for advanced G/GEJ cancer is poor and new treatment modalities are urgently needed. MUC17 is a transmembrane…”
Get full text

Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry by Cotes Sanchís, Almudena, Gallego, Javier, Hernandez, Raquel, Arrazubi, Virginia, Custodio, Ana, Cano, Juana María, Aguado, Gema, Macias, Ismael, Lopez, Carlos, López, Flora, Visa, Laura, Garrido, Marcelo, Martínez Lago, Nieves, Fernández Montes, Ana, Limón, María Luisa, Azkárate, Aitor, Pimentel, Paola, Reguera, Pablo, Ramchandani, Avinash, Cacho, Juan Diego, Martín Carnicero, Alfonso, Granja, Mónica, Martín Richard, Marta, Hernández Pérez, Carolina, Hurtado, Alicia, Serra, Olbia, Buxo, Elvira, Vidal Tocino, Rosario, Jimenez-Fonseca, Paula, Carmona-Bayonas, Alberto, Buyukhatipoglu, Hakan

“…Background Second-line treatments boost overall survival in advanced gastric cancer (AGC). However, there is a paucity of information as to patterns of use and…”
Get full text

Organizing Pneumonia With Fatal Outcome After Adjuvant Chemotherapy with FOLFOX by Vargas, Andrés, Montironi, Carla, Buxó, Elvira

Get full text

DNA damage repair (DDR) gene mutations (mut) are predictors of response to platinum-based chemotherapy in advanced pancreatic cancer (PC) patients (pts) by Verdaguer, Helena, Guardiola-Fernandez, Magda, Mancuso, Francesco M, Acosta, Daniel, Buxó, Elvira, Hernando, Jorge, Diez, Marc, Laquente, Berta, Baraibar, Iosune, Ros, Javier, Garcia, Alejandro, Matito, Judit, Martin, Agatha, Sierra, Alexandre, Villacampa, Guillermo, Molero, Cristina, Miquel, Josep M, Vivancos, Ana, Dienstmann, Rodrigo, Macarulla, Teresa

“…Abstract only e16805 Background: Somatic DDR mut have been reported in close to 10% of PC samples. In this study we investigate their predictive value for…”
Get full text

The Role of Audiometry prior to High-Dose Cisplatin in Patients with Head and Neck Cancer by Caballero, Miguel, Mackers, Paula, Reig, Oscar, Buxo, Elvira, Navarrete, Pilar, Blanch, Jose L, Grau, Juan J

“…To analyze the role of audiometry in considering change to a less ototoxic treatment in head and neck cancer (HNC) patients. Consecutive patients prescribed…”
Get more information

Pneumatosis intestinalis due to 5-fluorouracil chemotherapy by Vargas, Andrés, Pagés, Mario, Buxó, Elvira

Get full text

Assessment of Response to Neoadjuvant Chemoradiotherapy by 18F-FDG PET/CT in Patients With Locally Advanced Esophagogastric Junction Adenocarcinoma by Sánchez-Izquierdo, Nuria, Perlaza, Pilar, Pagès, Mario, Buxó, Elvira, Rios, José, Rubello, Domenico, Colletti, Patrick M., Mayoral, Maria, Casanueva, Sebastian, Fernández-Esparrach, Gloria, Ginés, Angels, Fuster, David

“…PURPOSEThe outcome of locally advanced adenocarcinoma of the esophagogastric junction (AEG) treated with preoperative chemoradiotherapy is heterogeneous, and…”
Get full text

Dose-escalation of the first-in human phase I/Ib study of ABTL0812, a novel antitumor drug inhibiting the Akt/mTOR pathway in patients with advanced solid tumors by Vidal Boixader, Laura, Gaba, Lydia, Victoria, Iván, Brunet, Merce, Paredes, Pilar, Buxo, Elvira, Vilella, Teresa, Riu, Gisela, Cortal, Marc, Gomez-Ferreria, Mariana, Alfon, Jose, Domenech, Carles, Gascon, Pedro

“…Abstract only…”
Get full text

A predictive model for venous thromboembolism in patients with germ-cell tumors receiving chemotherapy by Gonzalez-Billalabeitia, Enrique, Luengo, Maria Isabel, Garcia del Muro, Xavier, Guma, Josep, Manneh, Ray, Aparicio, Jorge, Sanchez Munoz, Alfonso, Buxo, Elvira, Saenz, Alberto, Valverde, Claudia María, Fernandez, Antonio, Margeli, Mireia, Espinosa, Marta, Sastre, Javier, Jiménez-Fonseca, Paula, Campillo Fuentes, Juana Ascension, Cerezuela Fuentes, Pablo, Carmona Bayonas, Alberto, Hervas, David, Maroto, Pablo

“…Abstract only…”
Get full text

Pneumatosis intestinalis due to 5-fluorouracil chemotherapy by Vargas, Andrés, Pagés, Mario, Buxó, Elvira

Get more information

Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis by Visa, Laura, Jiménez-Fonseca, Paula, Martínez, Elena Asensio, Hernández, Raquel, Custodio, Ana, Garrido, Manuel, Viudez, Antonio, Buxo, Elvira, Echavarria, Ignacio, Cano, Juana María, Macias, Ismael, Mangas, Montserrat, de Castro, Eva Martínez, García, Teresa, Manceñido, Felipe Álvarez, Montes, Ana Fernández, Azkarate, Aitor, Longo, Federico, Serrano, Asunción Díaz, López, Carlos, Hurtado, Alicia, Cerdá, Paula, Serrano, Raquel, Gil-Negrete, Aitziber, Carnicero, Alfonso Martín, Pimentel, Paola, Ramchandani, Avinash, Carmona-Bayonas, Alberto

“…Advanced gastric cancer (AGC) is a common neoplasm in older adults. Nevertheless, there are few specific management data in the literature. The aim of this…”
Get full text